Diagnostic strategies in adrenal insufficiency.
Curr Opin Endocrinol Diabetes Obes
; 30(3): 141-153, 2023 06 01.
Article
in English
| MEDLINE | ID: covidwho-2303752
ABSTRACT
PURPOSE OF REVIEW Adrenal insufficiency (AI) is the clinical manifestation of deficient production of glucocorticoids with occasionally deficiency also in mineralocorticoids and adrenal androgens and constitutes a fatal disorder if left untreated. The aim of this review is to summarize the new trends in diagnostic methods used for determining the presence of AI. RECENT FINDINGS:
Novel aetiologies of AI have emerged; severe acute respiratory syndrome coronavirus 2 infection was linked to increased frequency of primary AI (PAI). A new class of drugs, the immune checkpoint inhibitors (ICIs) widely used for the treatment of several malignancies, has been implicated mostly with secondary AI, but also with PAI. Salivary cortisol is considered a noninvasive and patient-friendly tool and has shown promising results in diagnosing AI, although the normal cut-off values remain an issue of debate depending on the technique used. Liquid chromatography-mass spectrometry (LC-MS/MS) is the most reliable technique although not widely available.SUMMARY:
Our research has shown that little progress has been made regarding our knowledge on AI. Coronavirus disease 2019 and ICIs use constitute new evidence on the pathogenesis of AI. The short synacthen test (SST) remains the 'gold-standard' method for confirmation of AI diagnosis, although salivary cortisol is a promising tool.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Adrenal Insufficiency
/
COVID-19
Type of study:
Diagnostic study
/
Etiology study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Curr Opin Endocrinol Diabetes Obes
Journal subject:
Endocrinology
/
Metabolism
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS